189 related articles for article (PubMed ID: 34017265)
1. Cardioprotective Effect of Whole Body Periodic Acceleration in Dystrophic Phenotype
Uryash A; Mijares A; Esteve E; Adams JA; Lopez JR
Front Physiol; 2021; 12():658042. PubMed ID: 34017265
[TBL] [Abstract][Full Text] [Related]
2. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
Lopez JR; Kolster J; Zhang R; Adams J
J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons.
Lopez JR; Uryash A; Kolster J; Estève E; Zhang R; Adams JA
Mol Neurobiol; 2018 Nov; 55(11):8680-8694. PubMed ID: 29582400
[TBL] [Abstract][Full Text] [Related]
4. Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice.
Altamirano F; Perez CF; Liu M; Widrick J; Barton ER; Allen PD; Adams JA; Lopez JR
PLoS One; 2014; 9(9):e106590. PubMed ID: 25181488
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
Law ML; Prins KW; Olander ME; Metzger JM
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of Intracellular Ca
Lopez JR; Kolster J; Uryash A; Estève E; Altamirano F; Adams JA
Mol Neurobiol; 2018 Jan; 55(1):603-618. PubMed ID: 27975174
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
9. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
10. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
[TBL] [Abstract][Full Text] [Related]
11. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
[TBL] [Abstract][Full Text] [Related]
12. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
13. Neuronal nitric oxide synthase localizes to utrophin expressing intercalated discs and stabilizes their structural integrity.
Gonzalez JP; Crassous PA; Schneider JS; Beuve A; Fraidenraich D
Neuromuscul Disord; 2015 Dec; 25(12):964-76. PubMed ID: 26483274
[TBL] [Abstract][Full Text] [Related]
14. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
15. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
Rodrigues M; Echigoya Y; Fukada SI; Yokota T
J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
[TBL] [Abstract][Full Text] [Related]
16. Muscular nitric oxide synthase (muNOS) and utrophin.
Chaubourt E; Voisin V; Fossier P; Baux G; Israël M; De La Porte S
J Physiol Paris; 2002; 96(1-2):43-52. PubMed ID: 11755782
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium.
Wehling-Henricks M; Jordan MC; Roos KP; Deng B; Tidball JG
Hum Mol Genet; 2005 Jul; 14(14):1921-33. PubMed ID: 15917272
[TBL] [Abstract][Full Text] [Related]
18. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice.
Williams IA; Allen DG
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1969-77. PubMed ID: 17573457
[TBL] [Abstract][Full Text] [Related]
19. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
Jung C; Martins AS; Niggli E; Shirokova N
Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
[TBL] [Abstract][Full Text] [Related]
20. Intracellular calcium handling in ventricular myocytes from mdx mice.
Williams IA; Allen DG
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H846-55. PubMed ID: 17012353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
